{"id":49,"date":"2019-09-09T10:15:24","date_gmt":"2019-09-09T10:15:24","guid":{"rendered":"http:\/\/corakid.com\/home\/"},"modified":"2025-05-22T15:15:32","modified_gmt":"2025-05-22T15:15:32","slug":"home","status":"publish","type":"page","link":"https:\/\/corakid.com\/en\/home\/","title":{"rendered":"UMRS 1155 – Common and Rare Kidney Diseases"},"content":{"rendered":"

\u00a0<\/h2>\n

\u00a0<\/h2>\n

Maladies R\u00e9nales Fr\u00e9quentes et Rares : <\/strong>
des m\u00e9canismes mol\u00e9culaires \u00e0 la m\u00e9decine personnalis\u00e9e<\/strong><\/h2>\n

\u00a0<\/p>\n

CoRaKiD est une unit\u00e9 de recherche de l\u2019Inserm et de Sorbonne Universit\u00e9,<\/strong>
situ\u00e9e \u00e0 l\u2019h\u00f4pital Tenon. C’est la seule unit\u00e9 en France<\/strong>
dont les projets de recherche sont enti\u00e8rement consacr\u00e9s<\/strong>
\u00e0 l’\u00e9tude des maladies r\u00e9nales.<\/strong><\/h5>\n

\u00a0<\/p>\n

EN SAVOIR PLUS<\/strong><\/a><\/h5>\n

\u00a0<\/p>\n

Prochains S\u00e9minaires<\/h2>\n

Camille Cohen – CRI – Bich\u00e2t<\/h5>\n

Inflammatory fibroblasts drive fibrosis development in kidney by interacting with FOLR2+ macrophage.<\/p>\n

Vendredi 16 Mai \u00e0 14h30 – RdC B\u00e2timent Recherche<\/h6>\n

Publications<\/h2>\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a><\/p>\n

D\u00e9couvrez notre biblioth\u00e8que HAL<\/a><\/h5>\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n

Advances and challenges in kidney fibrosis therapeutics<\/a><\/h6>\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n

Endothelial-specific deletion of connexin 43 improves renal function and structure after acute kidney injury<\/a><\/h6>\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n

Systematic screening of Autosomal Dominant Tubulointerstitial Kidney Disease-MUC1 27dupC pathogenic variant through exome sequencing<\/a><\/h6>\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n

Genomic analysis of adult thrombotic microangiopathies in less than 3 days: From rapid to fast genomics to treatment <\/a><\/h6>\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n

Gastrointestinal Angiectasia in patients with chronic kidney disease: A matched case-control study<\/a><\/h6>\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n

Signaling through cAMP-Epac1 induces metabolic reprogramming to protect podocytes in glomerulonephritis.<\/a><\/h6>\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n

Kidney Injury and Hair-Straightening Products Containing Glyoxylic Acid<\/a><\/h6>\n

Events<\/h2>\n

Deux nouvelles \u00e9quipes <\/h5>\n

\ud83d\udd2c\ud83e\uddec L’\u00e9quipe 1 se consacre \u00e0 la compr\u00e9hension des facteurs g\u00e9n\u00e9tiques, des l\u00e9sions r\u00e9nales aigu\u00ebs (AKI) et de la lithiase r\u00e9nale, pour mieux pr\u00e9venir et stopper la progression des atteintes r\u00e9nales.
\ud83d\udc8a\ud83c\udfaf L’\u00e9quipe 2, quant \u00e0 elle, concentre ses efforts sur les approches th\u00e9rapeutiques innovantes, telles que l’inhibition de la fibrose et le d\u00e9veloppement de th\u00e9rapies cibl\u00e9es, dans le but de restaurer la sant\u00e9 des reins.<\/p>\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n

SFNDT<\/h3>\n

Trois projets financ\u00e9s par la SFNDT ! Mieux comprendre le r\u00f4le des clones my\u00e9lo\u00efdes dans la n\u00e9phrite interstitielle, celui de la MMP9 dans le cil, ou la modulation de la voie des kynur\u00e9nines dans l’IRA, tels sont les objectifs de Khalil El Karoui, R\u00e9mi Piedagnel et Juliette Hadchouel.<\/p>\n

D\u00e9couvrez notre laboratoire<\/h2>\n

\t\t